Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CARL
$15.05
-4.57%
CARL
· Carlsmed, Inc.
$15.05
-0.72 (-4.57%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$430.56M
Shares
27.30M
Volume · Oct 30
53.42K
Avg daily vol (3M)
111.94K
All webcasts
Earnings call · FY2025 Q3
Carlsmed, Inc. (CARL) Q3 2025 Earnings Call
Revenue
$13.07M
+98.4% YoY
Diluted EPS
-$0.40
Gross margin
75.9%
+3.1 pp YoY
Net income
-$8.53M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 6, 2025.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Revenue
Raised
full year 2025
|
$49M – $50M | — | $50.51M above |
SEC filing · Item 2.02
8-K earnings release
Filed Nov 6, 2025 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 6, 2025 · complete as-filed document